US Stock MarketDetailed Quotes

INBX Inhibrx Biosciences

Watchlist
  • 14.080
  • +0.100+0.72%
Close Nov 22 16:00 ET
  • 15.400
  • +1.320+9.38%
Post 20:01 ET
203.82MMarket Cap0.12P/E (TTM)

Inhibrx Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
44.18%-30.28M
-44.82%-80.09M
-49.65%-40.31M
-42.06%-129.01M
7.48M
-54.25M
-55.3M
-26.94M
-90.81M
Net income from continuing operations
15.30%-43.86M
3,344.63%1.83B
-24.39%-49.27M
-34.37%-154.96M
---7.21M
---51.79M
---56.36M
---39.61M
---115.33M
Operating gains losses
----
----
----
8,515.79%1.64M
--1.63M
--1K
--0
--2K
--19K
Depreciation and amortization
150.00%760K
61.90%476K
22.03%360K
-2.78%1.19M
--298K
--304K
--294K
--295K
--1.23M
Other non cash items
-71.14%486K
-70,144.49%-2B
8.90%465K
-91.92%131K
---4.83M
--1.68M
--2.85M
--427K
--1.62M
Change In working capital
185.28%9.36M
526.22%39.6M
-57.41%3.09M
-40.20%2.31M
--15.31M
---10.98M
---9.29M
--7.26M
--3.86M
-Change in receivables
6,600.00%260K
-4,608.70%-1.08M
1,108.51%474K
-183.90%-521K
---447K
---4K
---23K
---47K
--621K
-Change in prepaid assets
125.26%3.82M
46.05%-2.25M
-2,636.17%-1.19M
-1,741.52%-6.68M
--12.59M
---15.14M
---4.18M
--47K
--407K
-Change in payables and accrued expense
17.28%5.58M
1,094.53%45.6M
-25.67%5.73M
64.22%11.37M
--3.49M
--4.76M
---4.59M
--7.7M
--6.92M
-Change in other current assets
--33K
---2.16M
---1.42M
--0
--0
--0
--0
--0
---1.32M
-Change in other current liabilities
28.96%-336K
-10.94%-507K
-10.99%-495K
-11.11%-1.86M
---484K
---473K
---457K
---446K
---1.67M
-Change in other working capital
----
----
----
----
----
---119K
----
----
---1.1M
Cash from discontinued investing activities
Operating cash flow
44.18%-30.28M
-44.82%-80.09M
-49.65%-40.31M
-42.06%-129.01M
--7.48M
---54.25M
---55.3M
---26.94M
---90.81M
Investing cash flow
Cash flow from continuing investing activities
69.54%-247K
-283.28%-1.22M
-4,765.22%-1.12M
-569.53%-4.59M
-3.44M
-811K
-317K
-23K
-686K
Net PPE purchase and sale
69.54%-247K
-283.28%-1.22M
-4,765.22%-1.12M
-569.53%-4.59M
---3.44M
---811K
---317K
---23K
---686K
Cash from discontinued investing activities
Investing cash flow
69.54%-247K
-283.28%-1.22M
-4,765.22%-1.12M
-569.53%-4.59M
---3.44M
---811K
---317K
---23K
---686K
Financing cash flow
Cash flow from continuing financing activities
0
217.45%30.25M
53.67%41.43M
46.02%133.6M
-67.5M
199.89M
-25.75M
26.96M
91.5M
Proceeds from stock option exercised by employees
--0
----
----
----
----
--21K
----
----
----
Net other financing activities
----
----
53.67%41.43M
46.02%133.6M
--133.73M
----
----
--26.96M
--91.5M
Cash from discontinued financing activities
Financing cash flow
--0
217.45%30.25M
53.67%41.43M
46.02%133.6M
---67.5M
--199.89M
---25.75M
--26.96M
--91.5M
Net cash flow
Beginning cash position
17.85%226.86M
--0
--0
--0
--337.33M
--192.49M
--0
--0
--0
Current changes in cash
-121.08%-30.53M
----
----
----
----
--144.84M
----
----
----
End cash Position
-41.80%196.33M
17.85%226.86M
--0
--0
--0
--337.33M
--192.49M
--0
--0
Free cash flow
44.55%-30.53M
-46.18%-81.31M
-53.67%-41.43M
-46.02%-133.6M
--4.04M
---55.06M
---55.62M
---26.96M
---91.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 44.18%-30.28M-44.82%-80.09M-49.65%-40.31M-42.06%-129.01M7.48M-54.25M-55.3M-26.94M-90.81M
Net income from continuing operations 15.30%-43.86M3,344.63%1.83B-24.39%-49.27M-34.37%-154.96M---7.21M---51.79M---56.36M---39.61M---115.33M
Operating gains losses ------------8,515.79%1.64M--1.63M--1K--0--2K--19K
Depreciation and amortization 150.00%760K61.90%476K22.03%360K-2.78%1.19M--298K--304K--294K--295K--1.23M
Other non cash items -71.14%486K-70,144.49%-2B8.90%465K-91.92%131K---4.83M--1.68M--2.85M--427K--1.62M
Change In working capital 185.28%9.36M526.22%39.6M-57.41%3.09M-40.20%2.31M--15.31M---10.98M---9.29M--7.26M--3.86M
-Change in receivables 6,600.00%260K-4,608.70%-1.08M1,108.51%474K-183.90%-521K---447K---4K---23K---47K--621K
-Change in prepaid assets 125.26%3.82M46.05%-2.25M-2,636.17%-1.19M-1,741.52%-6.68M--12.59M---15.14M---4.18M--47K--407K
-Change in payables and accrued expense 17.28%5.58M1,094.53%45.6M-25.67%5.73M64.22%11.37M--3.49M--4.76M---4.59M--7.7M--6.92M
-Change in other current assets --33K---2.16M---1.42M--0--0--0--0--0---1.32M
-Change in other current liabilities 28.96%-336K-10.94%-507K-10.99%-495K-11.11%-1.86M---484K---473K---457K---446K---1.67M
-Change in other working capital -----------------------119K-----------1.1M
Cash from discontinued investing activities
Operating cash flow 44.18%-30.28M-44.82%-80.09M-49.65%-40.31M-42.06%-129.01M--7.48M---54.25M---55.3M---26.94M---90.81M
Investing cash flow
Cash flow from continuing investing activities 69.54%-247K-283.28%-1.22M-4,765.22%-1.12M-569.53%-4.59M-3.44M-811K-317K-23K-686K
Net PPE purchase and sale 69.54%-247K-283.28%-1.22M-4,765.22%-1.12M-569.53%-4.59M---3.44M---811K---317K---23K---686K
Cash from discontinued investing activities
Investing cash flow 69.54%-247K-283.28%-1.22M-4,765.22%-1.12M-569.53%-4.59M---3.44M---811K---317K---23K---686K
Financing cash flow
Cash flow from continuing financing activities 0217.45%30.25M53.67%41.43M46.02%133.6M-67.5M199.89M-25.75M26.96M91.5M
Proceeds from stock option exercised by employees --0------------------21K------------
Net other financing activities --------53.67%41.43M46.02%133.6M--133.73M----------26.96M--91.5M
Cash from discontinued financing activities
Financing cash flow --0217.45%30.25M53.67%41.43M46.02%133.6M---67.5M--199.89M---25.75M--26.96M--91.5M
Net cash flow
Beginning cash position 17.85%226.86M--0--0--0--337.33M--192.49M--0--0--0
Current changes in cash -121.08%-30.53M------------------144.84M------------
End cash Position -41.80%196.33M17.85%226.86M--0--0--0--337.33M--192.49M--0--0
Free cash flow 44.55%-30.53M-46.18%-81.31M-53.67%-41.43M-46.02%-133.6M--4.04M---55.06M---55.62M---26.96M---91.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data